Gland Pharma Limited

Gland Pharma Limited

Share · INE068V01023 (XBOM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Gland Pharma Limited
No Price
Closing Price XBOM 29.04.2026: 1.737,15 INR
29.04.2026 10:00
Current Prices from Gland Pharma Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
GLAND.NS
INR
29.04.2026 10:00
1.739,10 INR
-21,70 INR
-1,23 %
XBOM: MSE
MSE
GLAND.BO
INR
29.04.2026 09:59
1.737,15 INR
-23,65 INR
-1,34 %
Share Float & Liquidity
Free Float 48,17 %
Shares Float 79,36 M
Shares Outstanding 164,76 M
Company Profile for Gland Pharma Limited Share
Gland Pharma Limited engages in manufacturing and sale of injectable formulation in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical API products including synthesis of complex drug molecules, such as LMWH, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro intestinal, gynecological, hormones, neuro/Cns, ophthal/ontological, and other areas, as well as pain and analgesics, respirator, and vitamins, minerals and nutrients; and offers contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Company Data

Name Gland Pharma Limited
Company Gland Pharma Limited
Website https://www.glandpharma.com
Primary Exchange XBOM MSE
ISIN INE068V01023
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Shyamakant Giri
Market Capitalization 290 Mrd.
Country India
Currency INR
Employees 4,2 T
Address Plot No. 11 & 84, TSIIC Phase: IV, 502307 Hyderabad
IPO Date 2020-11-20
Dividends from 'Gland Pharma Limited'
Ex-Date Dividend per Share
14.08.2025 18,00 INR
16.08.2024 20,00 INR

Ticker Symbols

Name Symbol
MSE GLAND.BO
NSE GLAND.NS
More Shares
Investors who hold Gland Pharma Limited also have the following shares in their portfolio:
Dev Labtech Venture Limited
Dev Labtech Venture Limited Share
LYXOR EURO STOXX 50 (DR) UCITS ETF - DAILY HEDGED TO GBP - ACC
LYXOR EURO STOXX 50 (DR) UCITS ETF - DAILY HEDGED TO GBP - ACC ETF